Smith & Nephew (LON:SN) had its price target trimmed by Morgan Stanley from GBX 1,950 ($24.00) to GBX 1,940 ($23.87) in a research note issued to investors on Thursday morning, Digital Look reports. They currently have an overweight rating on the stock.
SN has been the subject of several other research reports. Credit Suisse Group decreased their price target on shares of Smith & Nephew from GBX 1,685 ($20.74) to GBX 1,675 ($20.61) and set a neutral rating for the company in a report on Thursday. Citigroup decreased their price target on shares of Smith & Nephew from GBX 1,700 ($20.92) to GBX 1,670 ($20.55) and set a neutral rating for the company in a report on Thursday, June 18th. JPMorgan Chase & Co. decreased their price target on shares of Smith & Nephew from GBX 1,633 ($20.10) to GBX 1,553 ($19.11) and set a neutral rating for the company in a report on Thursday. UBS Group reissued a neutral rating on shares of Smith & Nephew in a report on Tuesday, June 23rd. Finally, Jefferies Financial Group decreased their price target on shares of Smith & Nephew from GBX 2,160 ($26.58) to GBX 1,800 ($22.15) and set a buy rating for the company in a report on Tuesday, April 28th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of GBX 1,782.25 ($21.93).
Shares of SN stock opened at GBX 1,517.50 ($18.67) on Thursday. Smith & Nephew has a 12-month low of GBX 14.99 ($0.18) and a 12-month high of GBX 2,023 ($24.90). The firm has a market capitalization of $13.29 billion and a price-to-earnings ratio of 22.19. The company has a quick ratio of 0.96, a current ratio of 2.06 and a debt-to-equity ratio of 39.82. The firm has a fifty day moving average of GBX 1,587.56 and a 200-day moving average of GBX 1,632.17.
The business also recently announced a dividend, which will be paid on Wednesday, October 28th. Investors of record on Thursday, October 1st will be paid a $0.14 dividend. This represents a yield of 0.68%. The ex-dividend date is Thursday, October 1st. Smith & Nephew’s payout ratio is presently 43.86%.
In related news, insider Roland Diggelmann bought 2,125 shares of Smith & Nephew stock in a transaction that occurred on Thursday, May 14th. The stock was purchased at an average cost of GBX 1,510 ($18.58) per share, with a total value of £32,087.50 ($39,487.45).
About Smith & Nephew
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Article: Most Active Stocks: Dollar Volume vs Share Volume
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.